Maribavir

Key facts

Active substance
Maribavir
Therapeutic area
Infectious diseases
Decision number
P/42/2009
PIP number
Maribavir
Pharmaceutical form(s)
  • Tablets
  • Age-appropriate oral formulation
Condition(s) / indication(s)
Cytomegaloviral disease
Route(s) of administration
Oral use
Contact for public enquiries
Applicant: ViroPharma SPRL
E-mail: john.watson@viropharma.com
Country: United Kingdom
Phone: +44 2075721222
Fax: +44 2075721221
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating